⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

July 1, 1994Journal of Clinical Oncology

Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients?

Y Bastion B Coiffier

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1994.12.7.1340 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 8021723 Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients? Y BastionxY BastionSearch for articles by this author , B CoiffierxB CoiffierSearch for articles by this author https://doi.org/10.1200/JCO.1994.12.7.1340 First Page PDF © 1994 by American Society of Clinical Oncology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bastion et al. (1994) studied this question.

synapsesocial.com/papers/6a7598d687be37a05b16105d https://doi.org/10.1200/jco.1994.12.7.1340

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and DexamethasoneJournal of Clinical Oncology · 2026
2Image-Based Consensus Molecular Subtyping Refines Prognostication in Stage II/III Colorectal Cancer: A Retrospective Analysis of the SCOT TrialJournal of Clinical Oncology · 2026
3Per- and Polyfluoroalkyl Substance Exposure and Breast Cancer Incidence in the Sister StudyJournal of Clinical Oncology · 2026
4International Initiative on a Refined Staging System for Medullary Thyroid Cancer: A Multinational Multicenter StudyJournal of Clinical Oncology · 2026
5Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients With TP53 , STAG2 , and CDKN2A AlterationsJournal of Clinical Oncology · 2026
6Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology · 2026
7Stereotactic Ablative Radiotherapy Versus Surgical Resection for Early-Stage Non–Small Lung Cancer: An Emulated Target TrialJournal of Clinical Oncology · 2026
8Immunochemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer: A Randomized Controlled TrialJournal of Clinical Oncology · 2026
9Methylphenidate for Hematologic Cancer–Related Fatigue: A Randomized Clinical TrialJournal of Clinical Oncology · 2026
10Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4Journal of Clinical Oncology · 2026

More from Journal of Clinical Oncology